Once the redistribution of GFP-LC3 under the different conditions was confirmed, cells were mock-infected or infected with BEV, fixed at 16 h pi and immunolabeled with the anti-Mpro antibody to monitor virus infection. The gene discussed is MAP1LC3A; the disease is viral infectious disease.